The Association between Antidepressant Exposure and Birth Defects-Are We There Yet?

Katherine L. Wisner; Tim F. Oberlander; Krista F. Huybrechts

doi:10.1001/jamapsychiatry.2020.1512

The Association between Antidepressant Exposure and Birth Defects-Are We There Yet?

Katherine L. Wisner^*, Tim F. Oberlander, Krista F. Huybrechts

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Editorial › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1215-1216
Number of pages	2
Journal	JAMA Psychiatry
Volume	77
Issue number	12
DOIs	https://doi.org/10.1001/jamapsychiatry.2020.1512
State	Published - Dec 2020

Funding

Women’s Hospital from Eli Lilly, the manufacturer of duloxetine. Dr Wisner is supported by HD085601-Obstetric-Fetal Pharmacology Research Center. No other disclosures were reported.

ASJC Scopus subject areas

Psychiatry and Mental health

Access to Document

10.1001/jamapsychiatry.2020.1512

Cite this

@article{dab54df316fb4751b5bacd7c7f1597dd,

title = "The Association between Antidepressant Exposure and Birth Defects-Are We There Yet?",

author = "Wisner, {Katherine L.} and Oberlander, {Tim F.} and Huybrechts, {Krista F.}",

note = "Funding Information: Women{\textquoteright}s Hospital from Eli Lilly, the manufacturer of duloxetine. Dr Wisner is supported by HD085601-Obstetric-Fetal Pharmacology Research Center. No other disclosures were reported.",

year = "2020",

month = dec,

doi = "10.1001/jamapsychiatry.2020.1512",

language = "English (US)",

volume = "77",

pages = "1215--1216",

journal = "JAMA Psychiatry",

issn = "2168-622X",